ROIV (STOCKS)
Roivant Sciences Ltd. Common Shares
$34.040000
+0.420000 (+1.25%)
Prev close: $33.620000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Matthew Gline
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $24,591.49M
- Employees
- 750
- P/E (TTM)
- -77.61
- P/B (TTM)
- 5.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
9
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q1)
|
$-0.26 | $-0.34 | +0.0760 | +22.62% |
|
Mar 2026 (Q4)
|
$-0.58 | $-0.35 | -0.2277 | -64.63% |
|
Dec 2025 (Q3)
|
$-0.38 | $-0.32 | -0.0560 | -17.28% |
|
Sep 2025 (Q2)
|
$-0.17 | $-0.34 | +0.1710 | +50.15% |